SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-020197
Filing Date
2021-04-23
Accepted
2021-04-23 06:06:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A cnst-defa14a_20210602.htm DEFA14A 38002
2 GRAPHIC guyorupbm4hm000002.jpg GRAPHIC 110443
3 GRAPHIC guyorupbm4hm000001.jpg GRAPHIC 218321
  Complete submission text file 0001564590-21-020197.txt   479299
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38584 | Film No.: 21846601
SIC: 2834 Pharmaceutical Preparations